Walleye Capital
GWPH

Walleye Capital’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Walleye Capital’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,291
Closed -$257K – 2419
2019
Q3 		$264K Buy
+2,291
New +$348K 0.02% 1043
2019
Q2 		– Sell
-569
Closed -$98.4K – 2195
2019
Q1 		$96K Buy
+569
New +$84.7K 0.02% 1046

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MGIM
M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Walleye Capital's GWPH Position: Q4 2019 in Review

Walleye Capital sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2019, closing a stake of 2,291 shares — an estimated $257K sold.

Walleye Capital first reported a position in GWPH in Q1 2019 and held it in 2 quarters. The position peaked at $264K in Q3 2019. 318 funds tracked by Wall St. Rank hold GWPH as of Q4 2019.

  • Walleye Capital reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2019 after selling out during the quarter.
  • Walleye Capital sold 2,291 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2019, an estimated $257K.
  • Walleye Capital first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 2 quarters.
  • Walleye Capital's GW Pharmaceuticals Plc American Depositary Shares position peaked at $264K in Q3 2019.
  • 318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2019.

Based on Walleye Capital's 13F filing for Q4 2019, filed 14 Feb 2020.